tiprankstipranks
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
US Market
QNRX
Quoin Pharmaceuticals
RESEARCH TOOLSreports

Quoin Pharmaceuticals (QNRX) Financial Statements

379 Followers

Quoin Pharmaceuticals Financial Overview

Quoin Pharmaceuticals's market cap is currently $10.52M. The company's EPS TTM is $-1.74; its P/E ratio is ―; Quoin Pharmaceuticals is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -100.79K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -16.42M$ -9.53M$ -9.38M$ -9.26M$ -6.06M
EBITDA$ -16.32M$ -9.43M$ -9.27M$ -8.56M$ -20.27M
Net Income$ -15.80B$ -8.96M$ -8.69M$ -9.38M$ -21.46M
Balance Sheet
Cash & Short-Term Investments$ 3.82B$ 14.06M$ 10.69M$ 12.85M$ 7.48M
Total Assets$ 20.39B$ 15.71M$ 12.17M$ 14.46M$ 9.36M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.82B$ -3.62M$ -2.40M$ -2.86M$ -7.48M
Total Liabilities$ 7.27B$ 6.50M$ 6.51M$ 7.05M$ 8.70M
Stockholders' Equity$ 13.12M$ 9.20M$ 5.66M$ 7.41M$ 657.03K
Cash Flow
Free Cash Flow$ -13.54B$ -7.86M$ -7.86M$ -8.73M$ -6.35M
Operating Cash Flow$ -13.54B$ -7.86M$ -7.86M$ -8.48M$ -5.72M
Investing Cash Flow$ -4.28B$ -1.89M$ 2.19M$ -10.15M$ -625.00K
Financing Cash Flow$ 18.01B$ 10.97M$ 5.22M$ 14.01M$ 13.50M
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History

Income Statement >

Quoin Pharmaceuticals Debt to Assets

Balance Sheet >

Quoin Pharmaceuticals Cash Flow

Cash Flow >

Quoin Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >